CD19/CD20 CAR-T cells

CD19/CD20 chimeric antigen receptor T cells · Jonsson Comprehensive Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19/CD20 CAR-T cells, covering 2025-09-05 to 2025-09-05. Get the full timeline:

Most recent: Clinical Trial Update: Modified Immune Cells (CD19/CD20 CAR-T Cells) in Treating Patients With Recurrent or Refractory B-Cell Lymphoma or Chronic Lymphocytic Leukemia [Phase 1]

See pricing